Desk› Healthcare› Supriya Lifescience Ltd
Supriya Lifescience Ltd
Filing rhythm · 60 trading days
15 filings · 5 material · busiest 2026-08-13
What it files
Filings
15 in the window
-
18 August 2026
Concall TranscriptEarnings Call Transcript
Earnings Call Transcript of the Earning Call for Unaudited Financial Results for quarter ended June 30, 2026 is enclosed.
Company Update / Earnings Call Transcript View filing →
-
14 August 2026
Newspaper PublicationNewspaper Publication
Enclosed herewith Copy of Newspaper Publication of Results for quarter ended June 30, 2026.
Company Update / Newspaper Publication View filing →
-
14 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
Audio Link for outcome of Results Earnings Call for United Financial Results for quarter ended June 30, 2026 is enclosed.
Company Update / Analyst / Investor Meet View filing →
-
13 August 2026
Board OutcomeBoard Meeting Outcome for Outcome Of The Board Meeting Held On August 13, 2026
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held ....
Board Meeting / Outcome of Board Meeting View filing →
-
13 August 2026
ResultsUnaudited Financial Results For The Quarter Ended June 30, 2026.
Unaudited Financial Results for the quarter ended June 30, 2026 is enclosed.
Result / Financial Results View filing →
-
13 August 2026
Investor PresentationInvestor Presentation
Investor Presentation for Results Earnings Call for Unaudited Financial Results for quarter ended June 30,2026 is enclosed herewith.
Company Update / Investor Presentation View filing →
-
13 August 2026
Press ReleasePress Release / Media Release
Press Release for Unaudited Financial Results for quarter ended June 30, 2026 is enclosed herewith.
Company Update / Press Release / Media Release View filing →
-
10 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Intimation of the Earnings call for Unaudited Financial Results of the Company for the quarter ended June 30, 2026 is enclosed herewith.
Company Update / Analyst / Investor Meet View filing →
-
6 August 2026
Board MeetingBoard Meeting Intimation for Unaudited Financial Results For Quarter Ended June 2026
Supriya Lifescience Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve In terms of Regulation ....
Board Meeting / Board Meeting View filing →
-
23 July 2026
Newspaper PublicationNewspaper Publication
Please find attached copy of Newspaper Publication of Postal Ballot Notice.
Company Update / Newspaper Publication View filing →
-
21 July 2026
Postal BallotShareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please Find Attached Postal Ballot Notice of Supriya Lifescience Limited.
AGM/EGM / Postal Ballot View filing →
-
9 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Enclosed herewith is the Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018, received from RTA.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
23 June 2026
GeneralEmail Communication To Shareholders Regarding Dividend Taxation Provisions.
Email Communication to Shareholders regarding Dividend Taxation Provisions.
Company Update / General View filing →
-
15 June 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Intimation of Analyst / Investor Meeting is enclosed herewith.
Company Update / Analyst / Investor Meet View filing →
-
9 June 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Intimation of Investor/Analyst call is enclosed.
Company Update / Analyst / Investor Meet View filing →